CLINICAL STUDY SHOWS RAPID IMPROVEMENT IN JOINT FUNCTION

This new clinical study on Dynagenix Muscle+Joint Formula demonstrated that 40 mg/day of Dynagenix produced statistically significant improvements in joint comfort, stiffness, and function as early as 5 days after supplementation started.

The clinical study is currently not published, but we would like to provide you with more information on the trial. Please fill out the form on this page and we will contact you.

Study Highlights

Detailed Results on a Range of Mobility Issues

In the clinical study, 72 men and women (age 40-70) with Grade II osteoarthritis, received either 40 mg/day of Dynagenix or a matching placebo for 30 days. Key outcome measures tested were WOMAC pain, stiffness, and function; a 30-second Chair Stand Test; a 6-minute Walk Test; a Stair Climb Test; and knee flexion and range of motion. Biomarkers of inflammation were also evaluated. Subjects were assessed at baseline, 5, 15, and 30 days.

In addition to the fast-acting effects seen at 5 and 15 days, by 30 days, subjects consuming Dynagenix experienced:

• 47% improvement in joint comfort
• 47% reduction in joint stiffness
• 45% improvement in joint function
• 46% improvement in overall joint health

based on the WOMAC scale.

In functional testing, Dynagenix subjects saw 25% improved performance in a Chair Stand Test – a widely used diagnostic tool of physical function – at 2 weeks. At 4 weeks, they saw a 14% improvement in flexibility. At 30 days, Dynagenix subjects saw a 25% improvement in stair speed of navigation. These subjects improved completion in the Stair Climb Test by an average of 4 seconds. In a Walking Test, Dynagenix subjects improved distance walked in 6 minutes by 47 meters, an improvement of walking speed by 8 meters per minute.